ADIPOQ and metabolic dysfunction-associated steatotic liver disease: To date, in diverse populations, massive studies have explored the relationship between ADIPOQ gene single‐nucleotide polymorphisms (SNPs) and NAFLD risk, as rs1501299 and 266729 (Stefan, Haring, & Cusi, 2018).